Publication | Closed Access

TMAVA, a Metabolite of Intestinal Microbes, Is Increased in Plasma From Patients With Liver Steatosis, Inhibits γ-Butyrobetaine Hydroxylase, and Exacerbates Fatty Liver in Mice

InflammationIntestinal MicrobesHepatologyHost-microbe InteractionsMedicineLiver PhysiologyImmunologyLiver SteatosisPathologyHepatology InflammationExacerbates Fatty LiverHepatotoxicityLiver DiseaseFatty Liver DiseaseMetabolomicsIntestinal MicrobiotaMicrobiome